Lewis Cantley

Cited by

	All	Since 2019
Citations	246701	73212
h-index	229	119
i10-index	647	450

15000

7500

3750

11250

1985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024613 674 635 670 778 942 1146 1530 1718 2162 2336 2805 3110 4053 4172 4232 4113 4007 4168 4647 4762 5159 5246 6147 6467 7409 8280 9807 10617 11035 11770 11462 11362 11481 11883 12715 14046 12836 11682 10009

Public access

View all

286 articles

7 articles

available

not available

Based on funding mandates

Co-authors

John AsaraAssociate Professor Medicine, Harvard Medical School; Director, Beth Israel Deaconess Medical CenterVerified email at bidmc.harvard.edu
Costas LyssiotisProfessor of Physiology, University of MichiganVerified email at lyssiotis.com
Ji LuoNational Cancer InstituteVerified email at nih.gov
David FrumanProfessor of Molecular Biology & Biochemistry, UC IrvineVerified email at uci.edu
John BlenisProfessor of Pharmacology, Weill Cornell MedicineVerified email at med.cornell.edu
Alex TokerVerified email at bidmc.harvard.edu
Jason LocasaleDuke UniversityVerified email at alum.mit.edu
Brendan D. ManningHarvard UniversityVerified email at hsph.harvard.edu
Lucia Rameh PlantVanderbilt UniversityVerified email at vanderbilt.edu
C. Ronald KahnJoslin Diabetes Center and Harvard Medical SchoolVerified email at joslin.harvard.edu
Reuben ShawThe Salk Institute of Biological StudiesVerified email at salk.edu
Pier Paolo PandolfiDirector, Cancer Center and Cancer Research Institute, Beth Israel Deaconess Medical CenterVerified email at bidmc.harvard.edu
Ronald A. DePinhoMD AndersonVerified email at mdanderson.org
Steven ShoelsonHarvard Medical SchoolVerified email at joslin.harvard.edu
David R. KaplanHospital for Sick ChildrenVerified email at sickkids.ca
Gerburg WulfAssociate Professor in Medicine, Harvard Medical SchoolVerified email at bidmc.harvard.edu
Kurt AugerGSKVerified email at gsk.com
Pasi JanneDana Farber Cancer InstituteVerified email at dfci.harvard.edu
Malcolm WhitmanHarvardVerified email at hms.harvard.edu
Marcus D GoncalvesWeill Cornell New York Presbyterian HospitalVerified email at med.cornell.edu

Lewis Cantley

Dana Farber Cancer Center and Harvard Medical School

Verified email at med.cornell.edu

cancer metabolism signal transduction PI 3-Kinase Protein kinases


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Understanding the Warburg effect: the metabolic requirements of cell proliferation MG Vander Heiden, LC Cantley, CB Thompson science 324 (5930), 1029-1033, 2009	17062	2009
AKT/PKB signaling: navigating downstream BD Manning, LC Cantley Cell 129 (7), 1261-1274, 2007	7475	2007
The phosphoinositide 3-kinase pathway LC Cantley Science 296 (5573), 1655-1657, 2002	7381	2002
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling JA Engelman, K Zejnullahu, T Mitsudomi, Y Song, C Hyland, JO Park, ... science 316 (5827), 1039-1043, 2007	5516	2007
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate L Dang, DW White, S Gross, BD Bennett, MA Bittinger, EM Driggers, ... Nature 462 (7274), 739-744, 2009	4774	2009
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism JA Engelman, J Luo, LC Cantley Nature Reviews Genetics 7 (8), 606-619, 2006	4033	2006
Oncogenes and signal transduction LC Cantley, KR Auger, C Carpenter, B Duckworth, A Graziani, R Kapeller, ... Cell 64 (2), 281-302, 1991	3583	1991
SH2 domains recognize specific phosphopeptide sequences S Zhou, SE Shoelson, M Chaudhuri, G Gish, T Pawson, WG Haser, F King, ... Cell 72 (5), 767-778, 1993	3574	1993
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth HR Christofk, MG Vander Heiden, MH Harris, A Ramanathan, ... Nature 452 (7184), 230-233, 2008	3235	2008
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis GM DeNicola, FA Karreth, TJ Humpton, A Gopinathan, C Wei, K Frese, ... Nature 475 (7354), 106-109, 2011	2883*	2011
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway LC Cantley, BG Neel Proceedings of the National Academy of Sciences 96 (8), 4240-4245, 1999	2762	1999
Ras, PI (3) K and mTOR signalling controls tumour cell growth RJ Shaw, LC Cantley Nature 441 (7092), 424-430, 2006	2660	2006
PI3K pathway alterations in cancer: variations on a theme TL Yuan, LC Cantley Oncogene 27 (41), 5497-5510, 2008	2413	2008
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin RJ Shaw, KA Lamia, D Vasquez, SH Koo, N Bardeesy, RA DePinho, ... Science 310 (5754), 1642-1646, 2005	2404	2005
The PI3K pathway in human disease DA Fruman, H Chiu, BD Hopkins, S Bagrodia, LC Cantley, RT Abraham Cell 170 (4), 605-635, 2017	2355	2017
PI3K: downstream AKTion blocks apoptosis TF Franke, DR Kaplan, LC Cantley Cell 88 (4), 435-437, 1997	2204	1997
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress RJ Shaw, M Kosmatka, N Bardeesy, RL Hurley, LA Witters, RA DePinho, ... Proceedings of the National Academy of Sciences 101 (10), 3329-3335, 2004	2169	2004
Phosphoinositide kinases DA Fruman, RE Meyers, LC Cantley Annual review of biochemistry 67 (1), 481-507, 1998	2137	1998
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism H Ying, AC Kimmelman, CA Lyssiotis, S Hua, GC Chu, ... Cell 149 (3), 656-670, 2012	2069	2012
The structural basis for 14-3-3: phosphopeptide binding specificity MB Yaffe, K Rittinger, S Volinia, PR Caron, A Aitken, H Leffers, ... Cell 91 (7), 961-971, 1997	2019	1997

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors